Enzymatic analysis of recombinant Japanese encephalitis virus NS2B(H)-NS3pro protease with fluorogenic model peptide substrates

PLoS ONE

Volumn 7, Issue 5, 2012, Pages e36872-

  Junaid, Muhammad ^a,b   Chalayut, Chakard ^a   Torrejon, Anna Sehgelmeble ^b   Angsuthanasombat, Chanan ^a   Shutava, Iryna ^b   Lapins, Maris ^b   Wikberg, Jarl E S ^b   Katzenmeier, Gerd ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; NS2B(H) NS3PRO PROTEASE; SERINE PROTEINASE; UNCLASSIFIED DRUG; FLUORESCENT DYE; NS2B PROTEIN, FLAVIVIRUS; NS3 PROTEASE, DENGUE VIRUS; PEPTIDE; PEPTIDE HYDROLASE; RECOMBINANT PROTEIN; VIRUS PROTEIN;

ARTICLE; CATALYSIS; CONTROLLED STUDY; DENGUE VIRUS; ENZYME INHIBITION; ENZYME KINETICS; HYDROLYSIS; JAPANESE ENCEPHALITIS VIRUS; MOLECULAR CLONING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SEQUENCE ALIGNMENT; VIRUS GENOME; WEST NILE VIRUS; WESTERN BLOTTING; YELLOW FEVER VIRUS; ENZYMOLOGY; GENETICS; KINETICS; METABOLISM; METHODOLOGY;

CLONING, MOLECULAR; ENCEPHALITIS VIRUS, JAPANESE; FLUORESCENT DYES; KINETICS; PEPTIDE HYDROLASES; PEPTIDES; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84872051307     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036872     Document Type: Article

References (49)

1. Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, et al. (2000) Japanese encephalitis. J Neurol Neurosurg Psychiatry 68: 405–415.
2. Mukhopadhyay S, Kuhn RJ, Rossmann MG (2005) A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3: 13–22.
3. Halstead SB, Jacobson J (2008) Japanese encephalitis vaccines. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. Philadelphia: Elsevier. pp 311–352.
4. Burke DS, Lpeake CJ (1988) Japanese encephalitis. In: Monath TP, ed. The arboviruses: epidemiology and ecology. Boca Raton: CRC Press. pp 63–92.
5. Fischer M, Lindsey N, Staples JE, Hills S (2010) Centers for Disease Control and Prevention (CDC). Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59 RR-1: 1–27.
6. Hanna JN, Ritchie SA, Phillips DA, Lee JM, Hills SL, et al. (1999) Japanese encephalitis in north Queensland, Australia. Med J Aust 170: 533–536.
7. Gould EA, Solomon T, Mackenzie JS (2008) Does antiviral therapy have a role in the control of Japanese encephalitis? Antiviral Research 78: 140–149.
8. Misra UK, Kalita J (2010) Overview: Japanese encephalitis. Progress in Neurobiology 91: 108–120.
9. Beasley D, Lewthwaite P, Solomon T (2006) Current use and development of vaccines for Japanese encephalitis. Expert opinion on Biological Therapy 8: 95–106.
10. Solomon T (2003) Recent advances in Japanese encephalitits. Journal of Neuro Virology 9: 274–283.
11. Solomon T (2008) New vaccines for Japanese encephalitis. The Lancet Neurology 7: 116–118.
12. Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, et al. (2011) Estimated global incidence of Japanese encephalitis: a systematic review. Bulletin of the World Health Organization BLT.10.085233: 1–22.
13. Sampath A, Padmanabhan R (2009) Molecular targets for flavivirus drug discovery. Antiviral Res 81: 6–15.
14. Joy J, Mee NF, Kuan WL, Perlyn KZ, Wen TS, et al. (2010) Biochemical characterisation of Murray Valley encephalitis virus proteinase. FEBS Letters 584: 3149–3152.
15. Mueller NH, Yon C, Ganesh VK, Padmanabhan R (2007) Characterization of the West Nile virus protease substrate specificity and inhibitors. The International Journal of Biochemistry & Cell Biology 39: 606–614.
16. Bessaud M, Pastorino BAM, Peyrefitte CN, Rolland D, Grandadam M, et al. (2006) Functional characterization of the NS2B/NS3 protease complex from seven viruses belonging to different groups inside the genus Flavivirus. Virus Research 120: 79–90.
17. Lindenbach BD, Rice CM (2001) Flaviridae: the viruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. Philadephia: Lippincott-Raven. pp 991–1041.
18. Yang TC, Shiu SL, Chuang PH, Lin YJ, Wan L, et al. (2009) Japanese encephalitis virus NS2B-NS3 protease induces caspase 3 activation and mitochondria-mediated apoptosis in human dulloblastoma cells. Virus Research 143: 77–85.
19. Ryan MD, Monaghan S, Flint M (1998) Virus-encoded proteinases of the Flaviviridae. J Gen Virol 79: 947–959.
20. Tackett AJ, Chen Y, Cameron CE, Raney KD (2005) Multiple full-length NS3 molecules are required for optimal unwinding of oligonucleotide DNA in vitro. J Biol Chem 280: 10797–10806.
21. Lin CW, Huang HD, Shiu SY, Chen WJ, Tsai MH, et al. (2007) Functional determinants of NS2B for activation of Japanese encephalitis virus NS3 protease. Virus Research 127: 88–94.
22. Niyomrattanakit P, Yahorava S, Mutule I, Mutulis F, Petrovska R, et al. (2006) Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides. The Biochemical Journal 397: 203–211.
23. Wu CF, Wang SH, Sunc CM, Hub ST, Syu WJ (2003) Activation of dengue protease autocleavage at the NS2B–NS3 junction by recombinant NS3 and GST–NS2B fusion proteins. Journal of Virological Methods 114: 45–54.
24. Yusof R, Clum S, Wetzel M, Murthy HMK, Padmanabhan R (2000) Purified NS2B/NS3 serine protease of Dengue virus type 2 exhibits cofactor NS2B dependence for the cleavage of substrates with dibasic amino acids in vitro. J Biol Chem 275: 9963–9969.
25. Leung D, Schroder K, White H, Fang NX, Stoermer MJ, et al. (2001) Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J Biol Chem 276: 45762–45771.
26. Aleshin AE, Shiryaev SA, Strongin AY, Liddington RC (2007) Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold. Protein Sci 16: 795–806.
27. Erbel P, Schiering N, Arcy AD, Renatus M, Kroemer M, et al. (2006) Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol 13: 372–373.
28. Jan LR, Yang CS, Trent DW, Falgout B, Lai CJ (1995) Processing of Japanese encephalitis virus non-structural proteins: NS2B-NS3 complex and heterologous protease. J Gen Virol 76: 573–580.
29. Shiryaev SA, Ratnikov BI, Aleshin AE, Kozlov IA, Nelson NA, et al. (2007) Switching the Substrate Specificity of the Two-Component NS2B-NS3 Flavivirus Proteinase by Structure-Based Mutagenesis. Journal of Virology 81: 4501–4509.
30. Niyomrattanakit P, Winoyanuwattikun P, Chanprapaph S, Angsuthanasombat C, Panyim S, et al. (2004) Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation. J Virol 78: 13708–13716.
31. Liu Y, Kati W, Chen CM, Tripathi R, Molla A, et al. (1999) Use of a fluorescence plate reader for measuring kinetic parameters with inner filter effect correction. Anal Biochem 267: 331–335.
32. The UniProt Consortium (2012) Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 40: D71–D75.
33. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779–815.
34. Löhr K, Knox JE, Phong WY, Ma NL, Yin Z, et al. (2007) Yellow fever virus NS3 protease: peptide-inhibition studies. J Gen Virol 88: 2223–2227.
35. Li J, Lim SP, Beer D, Patel V, Wen D, et al. (2005) Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries J Biol Chem 280: 28766–28774.
36. Iempridee T, Thongphung R, Angsuthanasombat C, Katzenmeier G (2008) A comparative biochemical analysis of the NS2B(H) – NS3pro protease complex from four dengue virus serotypes. Biochimica et Biophysica Acta 1780: 989–994.
37. Khumthong R, Angsuthanasombat C, Panyim S, Katzenmeier G (2002) In Vitro Determination of Dengue Virus Type 2 NS2B-NS3 Protease Activity with Fluorescent Peptide Substrates. Journal of Biochemistry and Molecular Biology 35: 206–212.
38. Shiryaev SA, Ratnikov BI, Chekanov AV, Sikora S, Rozanov DV, et al. (2006) Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase. Biochem J. 393: 503–511.
39. Wichapong A, Pianwanit S, Sippl W, Kokpol S (2009) Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction. Journal of Molecular Recognition 23: 283–300.
40. Chappell KJ, Nall TA, Stoermer MJ, Fang NX, Tyndall JD, et al. (2005) Site-directed mutagenesis and kinetic studies of the West Nile Virus NS3 protease identify key enzyme-substrate interactions. J Biol Chem 280: 2896–2903.
41. Chambers TJ, Hahn CS, Galler R, Rice CM (1990) Flavivirus genome organization, expression and replication. Annu Rev Microbiol 44: 649–688.
42. Gouvea IE, Izidoro MA, Judice WA, Cezari MH, Caliendo G, et al. (2007) Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates. Arch Biochem Biophys 457: 187–196.
43. Chappell KJ, Stoermer MJ, Fairlie DP, Young PR (2006) Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies. J Biol Chem 281: 38448–38458.
44. Li J, Lim SP, Beer D, Patel V, Wen D, et al. (2005) Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. J Biol Chem 280: 28766–28774.
45. Salaemae W, Junaid M, Angsuthanasombat C, Katzenmeier G (2010) Structure-guided mutagenesis of active site residues in the dengue virus two-component protease NS2B-NS3. J Biomed Sci 17: 68.
46. Sumiyoshi H, Mori C, Fuke I, Morita K, Kuhara S, et al. (1987) Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 161: 497–510.
47. Nall TA, Chappell KJ, Stoermer MJ, Fang NX, Tyndall JD, et al. (2004) Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease. J Biol Chem 279: 48535–48542.
48. Robin G, Chappell K, Stoermer MJ, Hu SH, Young PR, et al. (2009) Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation. J Mol Biol 385: 1568–1577.
49. Johnston PA, Phillips J, Shun TY, Shinde S, Lazo JS, et al. (2007) HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus. Assay Drug Dev Technol 5: 737–750.